Therapy management and outcome of acute hydrocephalus secondary to intraventricular hemorrhage in adults

• Published in: Chinese neurosurgical journal 2024-06, Vol.10 (1), p.17-17
• Main Authors: Wang, Chaoyang, Bai, Jianuo, He, Qiheng, Jiao, Yuming, Zhang, Wenqian, Huo, Ran, Wang, Jie, Xu, Hongyuan, Zhao, Shaozhi, Wu, Zhiyou, Sun, Yingfan, Yu, Qifeng, Tang, Jinyi, Zeng, Xianwei, Yang, Wuyang, Cao, Yong
• Format: Article
• Language: English
• Subjects: Adults; Case reports; Clinical outcomes; Cohort analysis; Endoscopy; Etiology; Hematoma; Hemorrhage; Hydrocephalus; Intracerebral hemorrhage; Intracranial pressure; Intraventricular hemorrhage; Management; Mortality; Pathophysiology; Review; Systematic review; Therapy
• ISSN: 2095-9370; 2057-4967
• DOI: 10.1186/s41016-024-00369-0

Intraventricular hemorrhage (IVH) refers to bleeding within the brain's ventricular system, and hydrocephalus is a life-threatening complication of IVH characterized by increased cerebrospinal fluid accumulation in the ventricles resulting in elevated intracranial pressure. IVH poses significant challenges for healthcare providers due to the complexity of the underlying pathophysiology and lack of standardized treatment guidelines. Herein, we performed a systematic review of the treatment strategies for hydrocephalus secondary to IVH. This systematic review was prospectively registered with PROSPERO (CRD42023450786). The search was conducted in PubMed, Cochrane Library, and Web of Science on July 15, 2023. We included original studies containing valid information on therapy management and outcome of hydrocephalus secondary to primary, spontaneous, and subarachnoid or intracranial hemorrhage following IVH in adults that were published between 2000 and 2023. Glasgow Outcome Scale (GOS) or modified Ranking Scale (mRS) scores during follow-up were extracted as primary outcomes. The risk of bias was assessed using the Newcastle-Ottawa Scale for Cohort Studies or Cochrane Risk of Bias 2.0 Tool. Two hundred and seven patients from nine published papers, including two randomized controlled trials, were included in the analysis. The GOS was used in five studies, while the mRS was used in four. Seven interventions were applied, including craniotomy for removal of hematoma, endoscopic removal of hematoma with/without endoscopic third ventriculostomy (ETV), traditional external ventricular drainage (EVD), and various combinations of EVD, lumbar drainage (LD), and intraventricular fibrinolysis (IVF). Endoscopic removal of hematoma was performed in five of nine studies. Traditional EVD had no obvious benefit compared with new management strategies. Three different combinations of EVD, LD, and IVF demonstrated satisfactory outcomes, although more studies are required to confirm their reliability. Removal of hematoma through craniotomy generated reliable result. Generally, endoscopic removal of hematoma with ETV, removal of hematoma through craniotomy, EVD with IVF, and EVD with early continuous LD were useful. EVD is still crucial for the management of IVH and hydrocephalus. Despite a more reliable result from the removal of hematoma through craniotomy, a trend toward endoscopic approach was observed due to a less invasive profile.